IBRUTINIB WITH RITUXIMAB (IR) AND SHORT COURSE R‐HYPERCVAD/MTX IS VERY EFFICACIOUS IN PREVIOUSLY UNTREATED YOUNG PTS WITH MANTLE CELL LYMPHOMA (MCL). (12th June 2019) - Wang, M.; Jain, P.; Zhang, S.; Nomie, K.; Wang, L.; Oriabure, O.; Nogueras Gonzales, G.; Zhang, L.; Wagner‐Bartak, N.; Hagemeister, F.; Samaniego, F.; Westin, J.; et al.